Catheter Precision shares jump 19.15% premarket after reporting 95% revenue growth and making an acquisition.

Catheter Precision surged 19.15% in premarket trading following a report that the medical devices company announced a 95% revenue growth and a strategic acquisition. Despite reporting a net loss of $17.2 million for 2025 compared to $16.6 million in 2024, the significant revenue increase and acquisition signal strong growth momentum, likely driving investor optimism and the sharp premarket price rise.